Romidepsin
BTCRC-HEM15-028
Phase 2 small_molecule terminated
Quick answer
Romidepsin for Lymphoma, T-Cell, Peripheral is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Lymphoma, T-Cell, Peripheral
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated